Sorensen Mel 4
4 · Galera Therapeutics, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Sorensen Mel
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-28+264,400→ 264,400 totalExercise: $2.24Exp: 2032-02-27→ Common Stock (264,400 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 28, 2022.